H Mukae, J Kadota, S Kohno, S Kusano, T Morikawa, S Matsukura and K Hara
Third Department of Internal Medicine, Miyazaki Medical College, Japan.

To study the role of T cells in diffuse panbronchiolitis (DPB), we investigated T-cell subsets in bronchoalveolar lavage fluid (BALF) or 33 patients with DPB, nine patients with bronchiectasis, and 20 healthy volunteers. BALF from DPB patients contained a higher percentage of neutrophils than that from patients with bronchiectasis or healthy volunteers, whereas the percentage of lymphocytes was similar in the three groups. DPB patients, however, had a higher number of lymphocytes and a reduced CD4/CD8 ratio compared with the other subjects. A two- color analysis of T-cell subsets in peripheral blood and BALF revealed a significant increase in the percentage and number of CD8+HLA-DR+ cells and in the number of CD4+HLA-DR+ cells in BALF of DPB patients. The expression of the adhesion molecules CD 11a and CD18 on lung CD3+ cells was enhanced over that on blood CD3+ cells in DPB patients. However, there was no significant difference in the expression of these antigens in peripheral blood or BALF among the groups. There was no significant relationship between BALF interleukin (IL)-8 and lymphocyte accumulation in the lungs of the DPB patients, whereas a significant correlation between the percentage of neutrophils and IL-8 levels in BALF of DPB patients was observed. After treatment with macrolide antibiotics, a significant reduction in the number of lymphocytes and activated CD8+ cells and an elevation in the CD4/CD8 ratio in BALF of DPB patients was observed. Our findings suggest an activation of CD8+ cells in the airway lumen of DPB patients, supporting the hypothesis that lymphocytes are important cellular components of bronchial inflammation in DPB.

This article has been cited by other articles:

				V. Poletti, G. Casoni, M. Chilosi, and M. Zompatori Diffuse panbronchiolitis Eur. Respir. J., October 1, 2006; 28(4): 862 - 871. [Abstract] [Full Text] [PDF]

				S C Bell, S L Senini, and J G McCormack Macrolides in cystic fibrosis Chronic Respiratory Disease, April 1, 2005; 2(2): 85 - 98. [Abstract] [PDF]

				M. J. Schultz Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis J. Antimicrob. Chemother., July 1, 2004; 54(1): 21 - 28. [Abstract] [Full Text] [PDF]

				T. Nagata, H. Mukae, J. Kadota, T. Hayashi, T. Fujii, M. Kuroki, R. Shirai, K. Yanagihara, K. Tomono, T. Koji, et al. Effect of Erythromycin on Chronic Respiratory Infection Caused by Pseudomonas aeruginosa with Biofilm Formation in an Experimental Murine Model Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2251 - 2259. [Abstract] [Full Text] [PDF]

				J.-i. Kadota, H. Mukae, T. Fujii, M. Seki, K. Tomono, and S. Kohno Clinical Similarities and Differences Between Human T-Cell Lymphotropic Virus Type 1-Associated Bronchiolitis and Diffuse Panbronchiolitis Chest, April 1, 2004; 125(4): 1239 - 1247. [Abstract] [Full Text] [PDF]

				B. K. Rubin and M. O. Henke Immunomodulatory Activity and Effectiveness of Macrolides in Chronic Airway Disease Chest, February 1, 2004; 125(2_suppl): 70S - 78S. [Abstract] [Full Text] [PDF]

				Y. Kaneko, K. Yanagihara, M. Seki, M. Kuroki, Y. Miyazaki, Y. Hirakata, H. Mukae, K. Tomono, J.-i. Kadota, and S. Kohno Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L847 - L853. [Abstract] [Full Text] [PDF]

				T Hiratsuka, H Mukae, H Iiboshi, J Ashitani, K Nabeshima, T Minematsu, N Chino, T Ihi, S Kohno, and M Nakazato Increased concentrations of human {beta}-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax, May 1, 2003; 58(5): 425 - 430. [Abstract] [Full Text] [PDF]

				H Ishii, H Mukae, J Kadota, H Kaida, T Nagata, K Abe, S Matsukura, and S Kohno High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia Thorax, January 1, 2003; 58(1): 52 - 57. [Abstract] [Full Text] [PDF]

				H Mukae, H Iiboshi, M Nakazato, T Hiratsuka, M Tokojima, K Abe, J Ashitani, J Kadota, S Matsukura, and S Kohno Raised plasma concentrations of {alpha}-defensins in patients with idiopathic pulmonary fibrosis Thorax, July 1, 2002; 57(7): 623 - 628. [Abstract] [Full Text] [PDF]

				J.-i. Ashitani, H. Mukae, T. Hiratsuka, M. Nakazato, K. Kumamoto, and S. Matsukura Elevated Levels of {alpha}-Defensins in Plasma and BAL Fluid of Patients With Active Pulmonary Tuberculosis Chest, February 1, 2002; 121(2): 519 - 526. [Abstract] [Full Text] [PDF]

				H. Mukae, H. Taniguchi, N. Matsumoto, H. Iiboshi, J.-i. Ashitani, S. Matsukura, and Y. Nawa Clinicoradiologic Features of Pleuropulmonary Paragonimus westermani on Kyusyu Island, Japan Chest, August 1, 2001; 120(2): 514 - 520. [Abstract] [Full Text] [PDF]

				J.-i. Kadota, H. Mukae, K. Tomono, and S. Kohno High Concentrations of {beta}-Chemokines in BAL Fluid of Patients With Diffuse Panbronchiolitis Chest, August 1, 2001; 120(2): 602 - 607. [Abstract] [Full Text] [PDF]

				M Gaga, A M Bentley, M Humbert, J Barkans, F O'Brien, C G Wathen, A B Kay, and S R Durham Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis Thorax, August 1, 1998; 53(8): 685 - 691. [Abstract] [Full Text]

				R. J. Harbeck Clin. Vaccine Immunol., May 1, 1998; 5(3): 271 - 277. [Full Text]